logo
Plus   Neg
Share
Email

Britvic Q1 Revenues Rise; Says Confident Of Meeting FY Market Expectations

Soft drinks maker Britvic plc (BVIC.L) reported Tuesday that its first-quarter revenue was 351.0 million pounds, an increase of 4.3% on the prior year on a constant currency basis. The strong start to the year was underpinned by volume growth of 3.9%.

GB reported a 2.2% increase in revenue. GB carbonates continued its outperformance of the market with a revenue increase of 5.5%. Pepsi Max and 7UP were both in strong growth, as was R Whites, benefiting from its relaunch last year.

France revenue increased 6.3% with the branded portfolio in strong growth, led by Fruit Shoot and Pressade. Ireland revenue increased 6.4%.

The International division reported a 19.8% increase in revenue, largely as a result of a 14.1% increase in volume. Brazil generated a 7.9% increase in revenue.

Simon Litherland, Chief Executive, said, "The new financial year has started well .... Encouragingly all our key markets have delivered revenue growth. Whilst the external environment remains uncertain, we are confident that the strong execution of our marketing and innovation plans combined with disciplined revenue management and our cost saving initiatives will deliver full year results in line with market expectations."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
RELATED NEWS
Follow RTT